Home › Research › Inflammation and the immune system
The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation
Young Min, Yoon-Seob Lee, Juwon Lee, Da-Young Keum, Joo-Young Gwag, Soyeon Jeon, Heejin Jo, Sung-Ung Kang. Brain Sciences, 2025-11-19
Topic: Brain proteins, microglia and lab models
Plain-language summary
Dementia is a growing global health concern in aging societies, leading to a progressive decline in cognitive function that severely impairs daily life. Despite the growing burden, effective preventive and therapeutic strategies remain elusive, emphasizing the urgent need for novel interventions. Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer's disease (AD). Chronic activation of central nervous system immune cells, particularly microglia, exacerbates neurodegeneration and establishes a self-perpetuating cycle of inflammation and cognitive decline. This review focuses on emerging research exploring the cGAS-STING pathway's role in dementia, examining its potential as a diagnostic and therapeutic target. The cGAS-STING pathway, integral to innate immune responses, may contribute to the chronic neuroinflammation seen in neurodegenerative diseases. By targeting this pathway, new strategies could mitigate the inflammatory processes that drive neuronal loss, offering a promising avenue for therapeutic development in dementia.
What this study adds
Evidence grade: Low
This review examines whether the cGAS-STING pathway could be a target for diagnosing and treating dementia by reducing chronic neuroinflammation. It does not report testing any treatment in people, so any therapy based on this idea remains unproven.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Min, Y., Lee, Y.-S., Lee, J., Keum, D.-Y., Gwag, J.-Y., Jeon, S., et al. (2025). The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation. Brain Sciences. https://doi.org/10.3390/brainsci15111241
Vancouver
Min Y, Lee Y.-S, Lee J, Keum D.-Y, Gwag J.-Y, Jeon S, et al. The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation. Brain Sciences. 2025. doi:10.3390/brainsci15111241. PMID: 41300248.
BibTeX
@article{min2025-41300248,
author = {Min, Young and Lee, Yoon-Seob and Lee, Juwon and Keum, Da-Young and Gwag, Joo-Young and Jeon, Soyeon and Jo, Heejin and Kang, Sung-Ung},
title = {{The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation}},
journal = {Brain Sciences},
year = {2025},
doi = {10.3390/brainsci15111241},
pmid = {41300248},
url = {https://doi.org/10.3390/brainsci15111241}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer's disease (AD).
- Chronic activation of central nervous system immune cells, particularly microglia, exacerbates neurodegeneration and establishes a self-perpetuating cycle of inflammation and cognitive decline.
- This review focuses on emerging research exploring the cGAS-STING pathway's role in dementia, examining its potential as a diagnostic and therapeutic target.
- The cGAS-STING pathway, integral to innate immune responses, may contribute to the chronic neuroinflammation seen in neurodegenerative diseases.
- By targeting this pathway, new strategies could mitigate the inflammatory processes that drive neuronal loss, offering a promising avenue for therapeutic development in dementia.
Why it matters
This review examines whether the cGAS-STING pathway could be a target for diagnosing and treating dementia by reducing chronic neuroinflammation. It does not report testing any treatment in people, so any therapy based on this idea remains unproven.
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Brain Sciences) |
| Journal's citation record | 1 / 4 | Brain Sciences: journal h-index 115 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Sung-Ung Kang: h-index 21 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41300248) |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 29.
Related studies in Inflammation and the immune system from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.